These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 22369306)

  • 21. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
    Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dysplastic lesions in inflammatory bowel disease: molecular pathogenesis to morphology.
    Matkowskyj KA; Chen ZE; Rao MS; Yang GY
    Arch Pathol Lab Med; 2013 Mar; 137(3):338-50. PubMed ID: 23451745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The lymphatic system controls intestinal inflammation and inflammation-associated Colon Cancer through the chemokine decoy receptor D6.
    Vetrano S; Borroni EM; Sarukhan A; Savino B; Bonecchi R; Correale C; Arena V; Fantini M; Roncalli M; Malesci A; Mantovani A; Locati M; Danese S
    Gut; 2010 Feb; 59(2):197-206. PubMed ID: 19846409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential avenues for immunotherapy of colitis-associated neoplasia.
    Waldner MJ; Neurath MF
    Immunotherapy; 2012 Apr; 4(4):397-405. PubMed ID: 22512634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Role of Proinflammatory Pathways in the Pathogenesis of Colitis-Associated Colorectal Cancer.
    Luo C; Zhang H
    Mediators Inflamm; 2017; 2017():5126048. PubMed ID: 28852270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytokines in colitis associated cancer: potential drug targets?
    Waldner MJ; Neurath MF
    Inflamm Allergy Drug Targets; 2008 Sep; 7(3):187-94. PubMed ID: 18782026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of Inflammation in the Development of Colorectal Cancer.
    Muthusami S; Ramachandran IK; Babu KN; Krishnamoorthy S; Guruswamy A; Queimado L; Chaudhuri G; Ramachandran I
    Endocr Metab Immune Disord Drug Targets; 2021; 21(1):77-90. PubMed ID: 32901590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of macrophages on ulcerative colitis-associated carcinogenesis].
    Wang W; Zhou Y; Li X; Shen S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Jun; 37(6):637-41. PubMed ID: 22772418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colorectal cancer prognosis among patients with inflammatory bowel disease.
    Delaunoit T; Limburg PJ; Goldberg RM; Lymp JF; Loftus EV
    Clin Gastroenterol Hepatol; 2006 Mar; 4(3):335-42. PubMed ID: 16527697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammatory pathways in the early steps of colorectal cancer development.
    Mariani F; Sena P; Roncucci L
    World J Gastroenterol; 2014 Aug; 20(29):9716-31. PubMed ID: 25110410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Colon cancer in inflammatory bowel disease: recent trends, questions and answers.
    Viennot S; Deleporte A; Moussata D; Nancey S; Flourié B; Reimund JM
    Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S190-201. PubMed ID: 20117342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical expression of SP-NK-1R-EGFR pathway and VDR in colonic inflammation and neoplasia.
    Isidro RA; Cruz ML; Isidro AA; Baez A; Arroyo A; González-Marqués WA; González-Keelan C; Torres EA; Appleyard CB
    World J Gastroenterol; 2015 Feb; 21(6):1749-58. PubMed ID: 25684939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes of immunocytic phenotypes and functions from human colorectal adenomatous stage to cancerous stage: Update.
    Shi Y; Li Z; Zheng W; Liu X; Sun C; Laugsand JB; Liu Z; Cui G
    Immunobiology; 2015 Oct; 220(10):1186-96. PubMed ID: 26153874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inflammation, DNA methylation and colitis-associated cancer.
    Hartnett L; Egan LJ
    Carcinogenesis; 2012 Apr; 33(4):723-31. PubMed ID: 22235026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiogenesis and the immune response as targets for the prevention and treatment of colorectal cancer (review).
    Sharma RA; Dalgleish AG; Steward WP; O'Byrne KJ
    Oncol Rep; 2003; 10(5):1625-31. PubMed ID: 12883750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5-Aminosalicylic acid inhibits colitis-associated but not sporadic colorectal neoplasia in a novel conditional Apc mouse model.
    Koelink PJ; Robanus-Maandag EC; Devilee P; Hommes DW; Lamers CB; Verspaget HW
    Carcinogenesis; 2009 Jul; 30(7):1217-24. PubMed ID: 19420017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cysteinyl leukotrienes and their receptors: bridging inflammation and colorectal cancer.
    Savari S; Vinnakota K; Zhang Y; Sjölander A
    World J Gastroenterol; 2014 Jan; 20(4):968-77. PubMed ID: 24574769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Role of Th17 lymphocytes in pathogenesis of colorectal cancer].
    Karczewski J; Mazur M; Rychlewska-Hańczewska A; Adamski Z
    Postepy Hig Med Dosw (Online); 2014 Jan; 68():42-7. PubMed ID: 24491894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of mast cells in colorectal cancer development, the jury is still out.
    Heijmans J; Büller NV; Muncan V; van den Brink GR
    Biochim Biophys Acta; 2012 Jan; 1822(1):9-13. PubMed ID: 21146606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does interleukin-6 link explain the link between tumour necrosis, local and systemic inflammatory responses and outcome in patients with colorectal cancer?
    Guthrie GJ; Roxburgh CS; Horgan PG; McMillan DC
    Cancer Treat Rev; 2013 Feb; 39(1):89-96. PubMed ID: 22858249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.